21-34834414-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BS3_Supporting
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.801G>A (p.Met267Ile) is a missense variant which has a REVEL score < 0.50 (0.283) and a SpliceAI score ≤ 0.20 (Acceptor Loss = 0.01) (BP4). Transactivation assays demonstrating normal transactivation (80-115% of wt) (BS3_Supporting; PMID:34166225). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS3, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014356/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUNX1 | NM_001754.5 | c.801G>A | p.Met267Ile | missense_variant | 7/9 | ENST00000675419.1 | NP_001745.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUNX1 | ENST00000675419.1 | c.801G>A | p.Met267Ile | missense_variant | 7/9 | NM_001754.5 | ENSP00000501943.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151924Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248848Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134580
GnomAD4 exome AF: 0.0000899 AC: 131AN: 1457412Hom.: 0 Cov.: 32 AF XY: 0.0000870 AC XY: 63AN XY: 723974
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151924Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74208
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2023 | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 267 of the RUNX1 protein (p.Met267Ile). This variant is present in population databases (rs757570529, gnomAD 0.007%). This missense change has been observed in individual(s) with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) (PMID: 24523240, 27137476, 34166225). This variant is also known as p.Met240Ile. ClinVar contains an entry for this variant (Variation ID: 409818). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change does not substantially affect RUNX1 function (PMID: 34166225). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Acute myeloid leukemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 07, 2024 | - - |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Myeloid Malignancy Variant Curation Expert Panel | Jun 24, 2024 | NM_001754.5(RUNX1):c.801G>A (p.Met267Ile) is a missense variant which has a REVEL score < 0.50 (0.283) and a SpliceAI score ≤ 0.20 (Acceptor Loss = 0.01) (BP4). Transactivation assays demonstrating normal transactivation (80-115% of wt) (BS3_Supporting; PMID: 34166225). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS3, BP4. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at